News May 3, 2025 Alimentiv Partners with Image Analysis Group to Offer Best-in-Class AI Solution in Histology Endpoints for GI Drug Development A strategic alliance combining full-service clinical trial expertise with cutting-edge imaging analysis technology to accelerate precision medicine in gastroenterology London, Canada, May 3, 2025 – Alimentiv, a… Read Now
News May 1, 2025 Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego Dova’s advanced AI co-pilot, DovaVision ™, is an endoscopy reading tool for UC clinical trials that reveals and quantifies nuanced disease severity for actionable insights… Read Now
News Apr 23, 2025 Alimentiv Experts Share Latest Advancements in GI Clinical Trials at DDW 2025 April 23, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce its participation in the highly anticipated Digestive Disease Week (DDW), taking place May 3–6,… Read Now
News Feb 11, 2025 Alimentiv to Present Key Insights Into GI Research With Multiple Presentations and Posters at the 20th ECCO Congress February 12, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce multiple presentations and posters at the 20th Congress of ECCO (European Crohn’s and Colitis… Read Now
News Feb 3, 2025 Alimentiv and PhaseV Partner on Machine Learning-Based Solutions to Tackle Challenges in GI Clinical Trials February 3, 2025 – Alimentiv Inc., a global full-service GI Contract Research Organization (CRO), announced today it has entered a strategic partnership with PhaseV, a… Read Now
Article Feb 3, 2025 Connecting the Spots: How Histopathology Expertise Supports Spatial Transcriptomics Analysis The path to drug development is inherently complex. In preclinical stages of drug development, it is difficult to predict how a drug affects the heterogenous… Read Now
